Resultados de búsqueda - Katheen Mullane

MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis por Andrej Spec, John Pullman, George R. Thompson, William G. Powderly, Ellis Tobin, José A. Vázquez, Stephen A. Wring, David Angulo, Silvia Helou, Peter G. Pappas, Jose Vasquez, Luis Ostrosky‐Zeichner, Thomas F. Patterson, Barbara D. Alexander, Helen W. Boucher, Peter G. Pappas, Robert F. Betts, Mindy G. Schuster, Shmuel Shoham, Sanjay G. Revankar, David Mushatt, Roger Bedimo, Alison G. Freifeld, Minh Hong Nguyen, Eleftherios Mylonakis, Daniel H. Kett, Annette C. Reboli, Thomas J. Walsh, Stephanie M. Pouch, Nikolaos G. Almyroudis, David R. Andes, Susan Hadley, Michelle Barron, Katheen Mullane, Loren G. Miller